Adam Zhao

CEO at AnlongBio

Speaker

Founder of the AnlongBio/AnlongMed. Dr. Zhao is among the first class graduated from Biological Science and Biotechnology department at Tsinghua University in 1990. He received his Ph.D in molecular biology from University of Pittsburgh School of Medicine and MBA from University of Chicago in the United States. Dr. Zhao was a senior manager at Pfizer in US. After returning to China in 2003, he founded Beijing LongMed Inc. and later became partner of CASH and C-Bridge Capital. Dr. Zhao has over 30 years of industry experience and excellent investment achievements, invested in Innovent, BerryGenomics, ASLETIS, I-Mab, Laekna, and GKHT. Dr. Zhao is the founding Chairman of Tsinghua Alumni Association for School of Life Sciences，School of Medicine and School of Pharmaceutical Sciences, a senior member of BayHelix group. AnlongMed is a leading venture fund in Chinese life sciences and Biotech, focusing on biotech & biopharma, medical devices, life sciences and medical services in China. Dr. Zhao also founded AnlongBio in 2019, a leading player in genetic medicine discovery in China, focusing on gene therapy, iRNA, mRNA, and other genetic medicines, with a leading product in gene therapy for ophthalmology already in clinical stages. Outside of his professional life, Dr. Zhao is a DJ, soccer player, ski lover, and has three lovely daughters.